Q2 2024 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2024-08-14 · accession 0001104659-24-089652
$477.8M
Reported value
40
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $72.5M | 15.2% | 4,415,689 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $59.4M | 12.4% | 5,074,916 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $56.5M | 11.8% | 6,788,609 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $46.1M | 9.66% | 1,267,790 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $25.0M | 5.24% | 453,641 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $23.2M | 4.85% | 3,261,393 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $22.3M | 4.66% | 3,768,035 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $20.9M | 4.37% | 1,208,473 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $13.6M | 2.85% | 967,527 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $11.9M | 2.49% | 525,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $11.6M | 2.42% | 799,274 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $11.2M | 2.35% | 850,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $11.1M | 2.33% | 2,523,022 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $10.4M | 2.17% | 588,817 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $9.2M | 1.93% | 1,786,427 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $8.5M | 1.78% | 1,000,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.1M | 1.48% | 172,647 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $7.0M | 1.46% | 1,562,500 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $6.4M | 1.35% | 2,196,814 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.5M | 1.16% | 6,130,268 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $5.4M | 1.13% | 630,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $5.0M | 1.05% | 347,500 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $4.8M | 1.00% | 2,442,352 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $4.3M | 0.89% | 3,640,015 | Common | SOLE |
| 918385204 | VTVT | VTV THERAPEUTICS INC | $3.7M | 0.76% | 206,784 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $2.8M | 0.58% | 540,304 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.7M | 0.57% | 196,425 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $2.3M | 0.48% | 198,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.9M | 0.39% | 45,052 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.4M | 0.29% | 202,348 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.1M | 0.22% | 154,664 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $786,865 | 0.16% | 1,049,153 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $769,298 | 0.16% | 2,780,261 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $765,788 | 0.16% | 696,171 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $374,995 | 0.08% | 689,709 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $172,089 | 0.04% | 172,089 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $96,882 | 0.02% | 78,131 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $59,554 | 0.01% | 82,336 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $21,333 | 0.00% | 133,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $1,660 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.